Previous Article | Next Article 
J Virol, June 1998, p. 4765-4774, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mutations in the Leucine Zipper-Like Heptad Repeat
Sequence of Human Immunodeficiency Virus Type 1 gp41 Dominantly
Interfere with Wild-Type Virus Infectivity
Steve S.-L.
Chen,*
Sheau-Fen
Lee,
Huey-Jong
Hao, and
Chin-Kai
Chuang
Institute of Biomedical Sciences, Academia
Sinica, Taipei, Taiwan, Republic of China
Received 15 October 1997/Accepted 17 February 1998
 |
ABSTRACT |
It has been previously shown that a proline substitution for any of
the conserved leucine or isoleucine residues located in the leucine
zipper-like heptad repeat sequence of human immunodeficiency virus type
1 (HIV-1) gp41 renders viruses noninfectious and envelope (Env) protein
unable to mediate membrane fusion (S. S.-L. Chen, C.-N. Lee, W.-R.
Lee, K. McIntosh, and T.-M. Lee, J. Virol. 67:3615-3619, 1993;
S. S.-L. Chen, J. Virol. 68:2002-2010, 1994). To understand whether these variants could act as trans-dominant
inhibitory mutants, the ability of these mutants to inhibit wild-type
(wt) virus infectivity was examined. Comparable amounts of cell- and virion-associated gag gene products as well as
virion-associated gp41 were found in transfection with wt or mutant
HIV-1 provirus. Viruses obtained from coexpression of wt provirus with
mutant 566 or 580 provirus inhibited more potently the production of infectious virus than did viruses generated from cotransfection of wt
provirus with other mutant proviruses. Nevertheless, all viruses
produced from mixed transfection showed decreased infectivity compared
with that of the wt virus when a multinuclear-activation
-galactosidase induction assay was performed. The ability of wt Env
to induce cytopathic effects was inhibited by coexpression with mutant
Env. Coexpression of mutants inhibited the ability of the wt protein to
mediate virus-to-cell transmission, as demonstrated by an env
trans-complementation assay with a defective HIV-1 proviral vector. These observations indicated that mutant Env, per se, interferes with wt Env function. Moreover, cotransfection of wt and
mutant proviruses produced amounts of cell- and virion-associated gag gene products comparable to those produced by
transfection of wt provirus. Similar amounts of gp41 were also found in
virions generated from wt-mutant cotransfection as well as from wt
transfection alone. These results indicated that the inhibitory effect
conferred by mutants on the wt virus infectivity does not involve the
late steps of Gag protein assembly and budding, but they suggest that the wt and mutant Env proteins form a dysfunctional hetero-oligomer which is impaired in an early step of the virus replication cycle. Our
study demonstrates that mutations in the HIV-1 gp41 leucine zipper-like
heptad repeat sequence dominantly inhibit infectious virus production.
 |
INTRODUCTION |
The envelope (Env) glycoprotein of
human immunodeficiency virus type 1 (HIV-1), forming as a gp120-gp41
heterodimer, plays a crucial role in viral infectivity and
cytopathicity, as well as in viral transmission, pathogenesis, and cell
and tissue tropism. HIV replication is initiated by attachment of the
virus to the cell surface through the binding of viral extracellular
Env glycoprotein gp120 to the cell surface primary receptor CD4 and a
CXCR4 or CCR5 coreceptor, a member of the chemokine receptor family
(for reviews, see references 2, 6, 20, and
55). Subsequently, the transmembrane (TM) protein
gp41 mediates membrane fusion between viral and host cell membranes,
thereby depositing the viral core into the cytoplasm (for reviews, see
references 40 and 41). Nevertheless, the mechanism underlying gp41-mediated membrane fusion is
still not well understood.
The best-characterized mechanism of membrane fusion is that of
influenza virus mediated by hemagglutinin (HA) (7, 9, 64).
Infection by influenza virus begins with the HA-mediated binding of the
virus to a sialylated cellular receptor present on the surface of
target cells, followed by internalization of virions into cellular
endosomes by receptor-mediated endocytosis. HA consists of a trimer of
HA1 and HA2 heterodimers linked by a disulfide
bond. HA2 is a membrane-anchoring subunit forming the
trimeric coiled-coil structure responsible for the oligomerization of
the protein and membrane fusion. The HA1 subunit covers the inner core of the HA2 trimer. A change to an acidic pH in
endosomes induces conformational changes of HA, including the
displacement of HA1 from HA2 and formation of
the B-loop region of HA2 into an extended coiled-coil
structure, and exposes the N-terminal hydrophobic fusion peptide that
is initially buried inside the molecule to the target membrane.
Finally, membrane fusion between virus and target cells is triggered.
Topologically analogous to the trimeric stem region of HA2
in the HIV-1 TM protein is the leucine zipper-like motif, termed the
zipper motif, located approximately 30 residues from the N-terminal fusion peptide sequence of gp41 (Fig. 1).
This highly conserved motif, comprising a periodic repeat of leucine or
isoleucine residues at every seventh position over eight helical turns,
is explicit as a heptad repeat sequence, an extensive region containing
nonpolar residues in all a positions and in most
d positions when displayed on an
-helical wheel. Such an
arrangement of hydrophobic residues within a putative
-helix was
hypothesized to be structurally analogous to that of HA2,
forming a coiled coil and playing a role in Env subunit assembly and
virus fusion (18, 28).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of the HIV-1 gp41 ectodomain.
Amino acid residues are numbered according to their positions in the
HXB2 Env protein. The N-terminal leucine zipper-like heptad repeat
sequence is shown as the hatched arrow directed to the right, and its
amino acid sequence in single-letter code is indicated. The conserved
leucine and isoleucine residues located in this motif, which are
numbered and indicated by boldface, were each replaced by a proline
residue and examined in this study. The C-terminal -helical sequence
is illustrated as the hatched arrow directed to the left. This domain
forms a heterodimer with the N-terminal zipper motif helix, and
three molecules of heterodimers fold into a six-stranded helical
bundle. Within the bundle the three N-terminal helices constitute a
central, parallel, trimeric coiled-coil structure, whereas the three
C-terminal helices pack antiparallelly into the hydrophobic groves on
the surface of the N-terminal trimer. The N-glycosylation sites ( )
and intramolecular disulfide bond (C C) are also shown.
|
|
Previously, to study the role of this hydrophobic heptad repeat
sequence in the HIV-1 life cycle, we replaced each conserved leucine or
isoleucine residue located in this region with a proline residue, which
affected the
-helical structure more severely than any other amino
acid. The results showed that all of the mutant viruses were severely
impaired in virus infectivity and that mutant proteins were unable to
mediate syncytium formation with CD4+ cells (14,
16). Nonetheless, all mutant proteins still formed oligomeric
structures. Other investigators obtained similar findings when the
middle isoleucine residue was replaced by amino acid residues that
disrupted the
-helical structure less severely than the proline
residue (21, 59). Studies on a peptide consisting of a
segment corresponding to this heptad repeat region, DP107, and its
proline substitution analog have shown that DP107 possesses anti-HIV
activity and that the degree of the inhibitory effect correlates with
the
-helix content in solution (62). Moreover, the
destabilization effect of amino acid substitutions at Ile-573 on
coiled-coil structures in peptide models correlates with the phenotype
of virus infectivity and membrane fusion of mutants (59).
These studies collectively indicate that this coiled-coil domain is
important for virus infectivity and membrane fusion, although it is not
involved in formation of a prefusogenic oligomer.
Interestingly, the zipper motif is conserved not only among HIV-1
isolates but also among the TM proteins of other retroviruses (18). The feature of heptad repeat sequences is also
conserved in the fusion proteins of paramyxoviruses, influenza viruses, coronaviruses, and retroviruses (11, 42). Therefore, these conserved sequences may represent a class of structural motifs that can
be targeted by similar antiviral therapeutic approaches.
Dominant negative inhibition is a phenomenon in which the functions of
the wild-type (wt) gene products are inhibited or blocked by the
coexpressed defective mutants of the same genes (33). trans-dominant negative inhibitors have been widely explored
with various cellular and viral systems. A genetic intervention
strategy based on trans-dominant negative mutants of HIV-1
proteins is an alternative to current vaccine development and
pharmacological therapy for AIDS (26).
Numerous strategies to interfere with Env function have been proposed
as potential anti-HIV therapies. One approach involves the use of
trans-dominant mutant Env based on the oligomeric state of
the Env proteins of primate immunodeficiency viruses (19, 22, 29,
31, 43, 49, 50). A polar substitution of Glu for Val at amino
acid 2 of the hydrophobic fusion peptide sequence of gp41 inhibits
production of infectious virus and syncytium formation induced by the
wt Env (27). An HIV-2 Env mutant with an in-frame deletion
in the CD4-binding site interferes with the wt virus infectivity
(52). Recently, a gp41 cytoplasmic domain truncation Env
variant was shown to inhibit wt virus infectivity (15). The
mechanism responsible for the inhibitory effect conferred by the Env
mutants involves interference with the functional assembly of
oligomeric wt protein by coexpression with mutant Env, resulting in the
formation of a nonfunctional Env protein complex (15).
In this study, we attempted to use the HIV-1 gp41 heptad repeat
sequence as a model system to determine the feasibility of developing
an antiviral strategy targeting this highly conserved sequence. Since
the zipper motif Env mutants described previously are unable to mediate
syncytium formation but still form oligomeric structures, the ability
of these mutants to interfere with the wt virus infectivity was
examined. The results showed that mutants with mutations in this region
are able to dominantly inhibit the wt Env-mediated syncytia formation
and virus entry into host cells. Also, the study may have implications
for the design of trans-dominant negative Env mutants
targeting the conserved heptad repeat sequences of fusion proteins of
other membrane-enveloped viruses.
 |
MATERIALS AND METHODS |
Cells and antibodies.
HeLa-CD4-LTR-
-gal is a HeLa cell
line that expresses a high level of CD4 and contains a single
integrated copy of the
-galactosidase gene fused to the HIV-1 long
terminal repeat (LTR) (35). HeLa-CD4-LTR-
-gal, CV-1,
COS-1, and 293 cells were all cultured in Dulbecco's modified Eagle's
medium supplemented with 10% heat-inactivated fetal bovine serum.
SupT1 is a human CD4+ T-lymphoid cell line. PM1 is a
derivative of Hut 78, which is a human cutaneous T-cell lymphoma cell
line derived from the peripheral blood mononuclear cells of a patient
with Sezary syndrome (39). Hybridoma Chessie 8 produces a
murine monoclonal antibody (MAb) specific for gp160 and maps to amino
acid residues 727 to 732 of HIV-1LAI (1).
Hybridoma 183 (clone H12-5C) is a mouse MAb reactive with HIV-1 Gag p24
(17). SupT1, PM1, hybridoma Chessie 8, and hybridoma 183 were maintained in RPMI 1640 containing 10% fetal bovine serum.
Hybridomas were injected intraperitoneally into BALB/c mice to produce
ascitic fluids. HeLa-CD4-LTR-
-gal (from Michael Emerman), SupT1
(from James Hoxie), PM1 (from Marvin Reitz, Jr.), hybridoma 183 (from
Bruce Chesebro), and Chessie 8 (from George K. Lewis) were obtained
through the AIDS Research and Reference Reagent Program, National
Institute of Allergy and Infectious Diseases, National Institutes of
Health. Antisera obtained from the National Institutes of Health AIDS
Research and Reference Reagent Program also included sheep anti-gp120
(strain IIIB) from Michael Phelan and rabbit antiserum to HIV-1 p25/p24
Gag from Kathelyn Steimer (53).
Plasmids.
The wt proviral DNA clone HXB2gpt
(48) and mutant HXB2gpt proviruses that encode a
proline substitution in the zipper motif of gp41 (Fig. 1) have been
previously described (14, 16). The HXB2gpt
provirus is abbreviated as HXB2 hereafter for simplicity. Vaccinia
virus (VV)-based Env expression plasmids that encode the wt and zipper
motif mutant Env proteins were previously described (14).
pBaby is a simian virus 40 (SV40) late replacement expression vector
and was used to generate pBSX for expression of the Env protein of
strain HXB2. pSVE7 was cloned in an SV40-based vector that expresses
the HXB2 strain Env driven by the HIV-1 LTR. pSVE7
KS, also known as
pSVIIIenv
KS (3), is a defective env expressor with a deletion at the KpnI (at nucleotide position 6351) to
StuI (at nucleotide position 6834) sites of the
env gene. pHXBCAT
Bgl contains a defective HXB2 provirus
with an in-frame deletion between the two BglII sites at
nucleotides 7041 and 7621 in the env gene as well as a
substitution of the chloramphenicol acetyltransferase (CAT) gene
(cat) for the nef gene (32). pIIIextat
expresses Tat under control of the HIV-1 LTR. All of these plasmids
were previously described (15).
Construction of Env expression plasmids.
To construct
env expression vectors that express zipper motif mutant
proteins in the pSVE7 or pBSX backbone, the
KpnI-BamHI fragments, i.e., the DNA sequence from
nucleotide 6351 to 8475, of mutant HXB2 constructs were each
substituted for the corresponding sequence in pSVE7 or pBSX. This
version of pSVE7 contained the whole sequence of pSVE7 and a partial
sequence of a neomycin resistance gene (neo) under control
of an SV40 promoter. This partial sequence of the neo gene
was inserted between the two EcoRI sites, separated by 440 bp, which was outside the LTR and env coding sequences. pSVE7
KS was similarly treated to contain a sequence of the
neo gene and was used as a control. All constructed clones
were sequenced to confirm mutations in the zipper motif by dideoxy
chain termination with T7 Sequenase and the following oligonucleotides
as primers: GGCGCAGCGTCAATGACG (at nucleotides 7814 to 7831 of the HXB2 sequence) for forward sequencing and
GCTTGTGTAATTGTTAATTTCTCTGTCCCA (at nucleotides 8143 to 8114)
for reverse sequencing.
Plasmid DNA transfection.
CV-1 cells grown in six-well
plates were infected with wt VV (WR strain) and then transfected with
wt or with wt and mutant VV env expression plasmids in the
presence of Lipofectin reagent as previously described (14).
HeLa-CD4-LTR-
-gal cells grown in six-well plates were transfected
with pIIIextat and wt pSVE7 in the presence or absence of mutant pSVE7
plasmids by using Superfect transfection reagent according to the
protocol provided by Qiagen (Valencia, Calif.). 293 cells grown in
100-mm-diameter petri dishes were transfected either with proviral DNA
clones or with pSVE7-based expression plasmids and pIIIextat by a
standard calcium phosphate coprecipitation protocol as previously
described (15). COS-1 cells were transfected with pBSX-based
expression plasmids by a DEAE-dextran method as previously described
(16).
Western blot (immunoblot) analysis.
Two days after
transfection, cell lysates were prepared as previously described
(15). Briefly, culture media were spun at 1,200 rpm in a
Beckman GS-6R centrifuge for 5 min followed by centrifugation at 2,400 rpm in the same centrifuge for 20 min. Supernatants were layered over a
20% sucrose cushion prepared in phosphate-buffered saline and
centrifuged at 27,000 rpm in a Beckman SW41 rotor for 2 h at
4°C, and the viral pellets were lysed with phosphate-buffered saline
containing 1% Nonidet P-40 and 1% sodium deoxycholate. Equal volumes
of cell or virion lysates were resolved by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), blotted onto
nitrocellulose membranes (0.45-µm pore size), and analyzed by using a
biotin-streptavidin-amplified horseradish peroxidase system coupled
with an enhanced chemiluminescence assay (Amersham, Arlington Heights,
Ill.) as previously described (15).
Virus infection, RT assay, and virus titration.
Two
days after transfection, culture media from cells transfected with
HXB2 proviruses or with pHXBCAT
Bgl and env
expression plasmids were spun at 2,000 rpm in a Beckman GS-6R
centrifuge for 5 min, and supernatants were filtered through a
0.45-µm-pore-size membrane. One-milliliter aliquots of filtered
supernatants were concentrated by use of polyethylene glycol and
assayed for virion-associated reverse transcriptase (RT) activity
(16). Virus infectivity was assayed in SupT1 or PM1 cells by
using aliquots of virus containing 105 cpm (or as
specifically indicated for each experiment) of RT activity. SupT1
culture supernatants at different days postinfection were then
monitored for RT activity. Virus infectivity was also titrated on
HeLa-CD4-LTR-
-gal indicator cells by the MAGI (multinuclear activation of a galactosidase indicator) assay as previously described (35).
CAT assay.
CAT activity was determined 3 days after
infection of HeLa-CD4-LTR-
-gal or PM1 cells as previously described,
using aliquots of cell lysates containing equal amounts of proteins
(15). The percentage of acetylation of radioactive
chloramphenicol was quantitated by determining the relative signals of
acetylated products and the unreacted chloramphenicol with an Instant
Imager (Packard Instrument Company, Meriden, Conn.). The degree of
entry of defective virus into CD4+ cells mediated by Env
proteins supplied in trans was calculated by subtracting the
percentage of acetylation of the defective virus in the absence of Env
expression from that of the defective virus pseudotyped with wt or with
wt and mutant Env proteins.
 |
RESULTS |
Analysis of viral proteins expressed in cells transfected with
mutant HXB2 proviruses.
To analyze viral proteins expressed by
zipper motif mutants in the context of replication of a whole virus,
293 cells were transfected with equal amounts of wt or mutant HXB2
proviruses by a calcium phosphate coprecipitation method. Two days
after transfection, equal volumes of cell lysates were analyzed by
SDS-PAGE followed by Western blotting with rabbit anti-p25/p24. Similar levels of gag gene products were produced by the wt provirus
and all of the mutant proviruses (Fig.
2A). When lysates were analyzed with
anti-gp120, all transfections produced similar levels of cell-associated gp160 (Fig. 2B). Intracellular gp120 was detected in
the wt and some of the mutants (Fig. 2B). When lysates of transfected cells were analyzed with the Chessie 8 MAb, which is reactive with an
epitope located in the gp41 cytoplasmic domain, all mutant proviruses
except mutant 587 apparently produced less cell-associated gp41 than
the wt provirus (Fig. 2C). To examine viral proteins assembled into
mutant virions, virions were isolated by a standard sucrose cushion
centrifugation as previously reported (30). Equal aliquots
of virus lysates were then analyzed with these three antibodies.
Similar amounts of p24 were detected in the wt and mutant virions (Fig.
2A). gp120 was found associated with wt and mutant 566 virions but
could not be detected with other mutant virions (Fig. 2B). Amounts of
gp41 similar to or even greater than that detected in the wt virus were
detected in all mutant virions (Fig. 2C).

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of viral proteins encoded by wt and zipper
motif mutant HXB2 proviruses. 293 monolayers were transfected by a
standard calcium phosphate coprecipitation method with 10 µg each of
wt or mutant HXB2 proviruses as indicated. The numbers shown in
parentheses indicate the locations where the conserved leucine or
isoleucine residues in the gp41 zipper motif were replaced by a proline
residue. Mock-transfected cells were included as a negative control
(lane 1). Two days after transfection, lysates of cells and virions
were prepared as described in Materials and Methods. Equal aliquots of
cell lysates and virus fractions were separated by SDS-10% PAGE, and
proteins were visualized by Western immunoblotting analysis with rabbit
anti-p25/p24 (strain SF2) (A), sheep anti-gp120 (B), or
anti-gp41-specific Chessie 8 MAb (C).
|
|
Interference with infectious virus production by cotransfection
with the mutant HXB2 proviruses.
To examine whether mutant HXB2
could interfere with the wt virus infectivity, virus stocks were
generated from 293 cells transfected with wt or with wt and mutant
proviruses at a wt/mutant DNA ratio of 1:2. In each transfection the
amount of wt HXB2 DNA was held constant and pHXBCAT
Bgl DNA was added
to the wt provirus transfection to maintain a constant final DNA
concentration. Equal amounts of cell-free virus, as normalized by RT,
were used to challenge SupT1 cells, and RT activity was monitored after
infection. SupT1 cells infected with virus produced from wt
HXB2-transfected 293 cells began to produce RT 7 days after infection,
and the RT activity reached its peak 9 days after infection (Fig.
3). When viruses generated from
cotransfection with wt and mutant 566 proviruses or with wt and mutant
580 proviruses were used for SupT1 inoculation, there was a substantial
delay in the appearance of RT activity (Fig. 3). When viruses generated
from cotransfection with wt and mutant 559, wt and mutant 573, or wt
and mutant 587 were examined, there appeared to be no significant delay
in virus production (Fig. 3). This study indicated that mutants 566 and
580 exert an inhibitory effect on the production of infectious virus.
The other mutants did not seem to interfere with the production of infectious virus in this continuous virus growth study.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of cotransfection with wt and mutant HXB2
proviruses on production of infectious virus. 293 cells were
transfected with 5 µg of wt HXB2 or 5 µg of wt HXB2 plus 10 µg of
mutant HXB2 proviruses as indicated. The total amount of DNA in all
transfections was kept constant at 15 µg by adding pHXBCAT Bgl
plasmid DNA. Two days after transfection, culture supernatants were
collected, centrifuged, and passed through 0.45-µm-pore-size
membranes. Virions containing 5 × 104 cpm of RT
activity from each virus stock were used to challenge 2 × 106 SupT1 cells. The cultures were monitored for
virion-associated RT production at different times postinfection.
|
|
Quantitation of infectivity of viruses generated from
cotransfection with wt and mutant proviruses.
To quantitate the
infectivity of these mixed viruses, virus from each stock containing
equal amounts of RT activity was measured by MAGI assay with
HeLa-CD4-LTR-
-gal indicator cells (35). This method can
detect productive infection of a single viral particle by the ability
of viral Tat protein upon HIV-1 infection to transactivate the HIV-1
LTR-linked
-galactosidase gene. Virus infection was then monitored
by the appearance of foci of the target cells by using X-Gal
(5-bromo-4-chloro-3-indolyl-D-galactopyranoside) staining
under a light microscope 3 days postinfection. All viruses generated
from cotransfection with wt and mutant HXB2 showed a 64 to 99%
reduction in titer compared to that of the wt virus (Table
1). Consistent with Fig. 3,
cotransfection of wt provirus with mutant 559, 573, or 587 provirus
showed a lower degree of inhibition of virus infectivity than
cotransfection of wt provirus with mutant 566 or 580 provirus.
Collectively, these results demonstrated that coexpression of wt and
zipper motif mutant proviruses inhibits wt virus infectivity.
Interference with wt Env-induced cytopathic effects by
cotransfection with mutant proteins.
To understand whether mutant
proteins were responsible for the phenotype of inhibition of
infectivity of viruses obtained from cotransfection, the ability of
mutant proteins to inhibit wt Env-induced cytopathic effects was
examined. wt VV-infected CV-1 cells were transfected by a
liposome-mediated method with wt or with wt and mutant env
plasmids cloned in a VV vector (14) at different wt/mutant
DNA ratios. Transfected cells were mixed with SupT1 cells, and
syncytium formation was examined under a light microscope 18 h
after cocultivation. As summarized in Table 2, syncytium formation induced by the wt
Env was not detected when the wt/mutant plasmid DNA ratio was 1:3. At a
1:2 ratio of wt to mutant plasmid DNA, wt protein-mediated syncytium
formation was also significantly inhibited. When the wt/mutant plasmid
DNA ratio was set at 1:1, many fewer or even no syncytia were observed in the wt-mutant cotransfection compared to the amount found in the wt
transfection.
To confirm that the zipper motif mutant proteins interfered with wt
Env-induced cytopathic effects, the pSVE7 expression system
was also
employed. The 2.1-kb
KpnI-
BamHI fragments
isolated from
the mutant HXB2 proviruses were used to substitute for
the corresponding
sequence in a modified version of pSVE7 to yield
mutant pSVE7
plasmids. These mutants were examined for Env protein
expression
by Western blotting analysis. Except for mutant 559, which
showed
a slightly lower level, all mutant plasmids produced Env
proteins
at a level similar to or even slightly greater than that
produced
by the wt plasmid in the presence of pIIIextat during
transfection
(Fig.
4).
HeLa-CD4-LTR-

-gal cells were then cotransfected with
pIIIextat and
pSVE7 in the presence or absence of mutant plasmids
by the Superfect
transfection method. Two days after transfection,
cell cultures were
examined under a light microscope. No syncytia
or cytopathic effects
were observed in the culture that was transfected
with the
tat expression plasmid alone (Fig.
5A). Transfection
with wt pSVE7 together
with pIIIextat produced striking cytopathic
effects, including
syncytium formation and floating and dead cells
(Fig.
5B). In addition,
a large number of cells had undergone
fusion and lysis. In contrast,
cotransfection of wt and mutant
plasmids strikingly inhibited or
delayed the wt Env-induced cytopathic
effects (Fig.
5C to G). Although
a few syncytia were about to
form in cells cotransfected with mutant
573 or 587, the cytopathic
effects in these cultures were much delayed
compared to that found
with the wt transfection. Taken together, these
observations indicated
that zipper motif mutant proteins are able to
interfere with cytopathic
effects mediated by the wt protein.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 4.
Env proteins encoded by wt and mutant pSVE7 plasmids.
COS-1 cells were cotransfected by the DEAE-dextran method with 5 µg
each of wt or mutant pSVE7 plasmid in the presence of 2 µg of
pIIIextat. Two days after transfection, cell lysates were prepared and
equal amounts of cell lysates were subjected to SDS-PAGE followed by
Western blotting with sheep anti-gp120.
|
|

View larger version (107K):
[in this window]
[in a new window]
|
FIG. 5.
Inhibition of the wt Env-mediated cytopathic effects by
coexpression with wt and mutant Env proteins. HeLa-CD4-LTR- -gal
cells grown in six-well plates were transfected with 1 µg of
pIIIextat and 2 µg of wt pSVE7 in the presence or absence of 4 µg
of mutant pSVE7 plasmids as indicated, using 10 µl of Superfect
transfection reagent according to the Qiagen protocol. Transfection
with pIIIextat was used as a negative control (A). DNA of pSVE7 KS
was added to transfection mixtures to keep the total DNA amount in each
transfection constant. Two days after transfection, cell cultures were
photographed under a light microscope. Magnification, ×200.
|
|
Interference with wt Env-mediated viral transmission by mutant Env
proteins.
To confirm that zipper motif mutant Env proteins
conferred interference with wt virus infectivity, an env
trans-complementation assay utilizing a defective HIV-1 proviral
vector (32) was performed to study virus replication in
a context of virus-to-cell transmission. This assay determines the
ability of Env proteins to complement a defective pHXBCAT
Bgl
provirus for a single round of virus replication. 293 cells were
transfected with pHXBCAT
Bgl together with wt pSVE7 in the presence
or absence of mutant pSVE7 plasmids. The wt/mutant plasmid DNA ratio
was set to 1:1. Two days after transfection, culture supernatants were
filtered and their RT activity was determined. Viruses containing equal
amounts of RT activity from each transfection were used to infect
HeLa-CD4-LTR-
-gal cells. Three days after infection, cell lysates
were prepared and assayed for CAT activity. Viruses derived from
defective provirus transfection alone did not show entry into
CD4+ cells, as CAT activity was undetected (Fig.
6A, lane 1). wt Env successfully mediated
virus-to-cell transmission as evidenced by the increased CAT activity
compared with the Env-negative control (Fig. 6A, lane 2). In contrast,
mutant Env proteins did not support entry of the defective virus into
CD4+ cells (data not shown). On the other hand, wt-mutant
cotransfection decreased CAT activity by 49 to 71% compared with that
with wt transfection alone (Fig. 6A, lanes 3 to 7).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 6.
Virus-to-cell transmission of a defective provirus
mediated by wt and mutant Env coexpression. (A) wt/mutant pSVE7 DNA
ratio of 1:1. 293 cells were cotransfected with 10 µg of
pHXBCAT Bgl and 10 µg of wt pSVE7 or with 10 µg each of
pHXBCAT Bgl, wt, and mutant pSVE7 plasmids as indicated. Transfection
with the defective provirus alone was used as a control (lane 1).
Plasmid SVE7 KS was added to transfection mixtures to make the total
amount of DNA in each transfection constant. Two days after
transfection, cell-free viruses were prepared, and virus from each
stock containing 5 × 104 cpm of RT activity was
applied to subconfluent HeLa-CD4-LTR- -gal cells grown in
60-mm-diameter petri dishes. Unbound viruses were removed after
overnight incubation at 37°C, and fresh media were added to cultures.
Three days after transfection, cell lysates were prepared and assayed
for CAT activity. (B) wt/mutant pSVE7 DNA ratio of 1:2. Transfection
was performed as described for panel A except that 7.5 µg of
pHXBCAT Bgl, 5 µg of wt pSVE7, and 10 µg of various pSVE7 mutants
were used in transfection. Viruses with 2 × 105 cpm
of RT activity were applied to HeLa-CD4-LTR- -gal cells, and CAT
activity was assayed 3 days after infection.
|
|
To further address the interference with wt Env-mediated virus entry
conferred by mutant Env, recombinant viruses were generated
from 293 cells cotransfected either with the
cat-containing defective
provirus along with wt pSVE7 or with wt and mutant pSVE7 at a
wt/mutant
plasmid DNA ratio of 1:2. Defective viruses pseudotyped
with wt and
zipper motif Env mutants showed significant reductions,
ranging from 87 to 92%, in CAT activity compared with the defective
virus supplemented
with the wt protein alone (Fig.
6B). By comparing
Fig.
6A and B, it was
also noted that the interference with wt
Env-mediated virus entry
conferred by zipper motif mutants was
dependent on the amounts of
mutant plasmids used in cotransfection.
To examine whether wt Env-mediated virus entry measured by CAT activity
correlated with virus infectivity, mutants 566 and
573 were chosen for
more characterization. Mutants 566 and 573
represented the group of
mutants that showed a more pronounced
interference effect or a lesser
interference effect, respectively,
on infectious virus production (Fig.
3). Infectivity of recombinant
viruses generated from pHXBCAT

Bgl
cotransfection with wt pSVE7
or with wt and mutant pSVE7 at a wt/mutant
DNA ratio of 1:1 was
determined by MAGI assay. Virus derived from
cotransfection with
wt and mutant 566 showed a 55% reduction in CAT
activity, and
virus from cotransfection with wt and mutant 573 showed a
62%
reduction in infectivity, compared with that of virus obtained
from wt pSVE7 transfection alone (Table
1). In a separate experiment,
defective recombinant viruses were generated from cotransfection
of wt
and mutant 566 and of wt and mutant 573 at different wt/mutant
DNA
ratios. The degree of inhibition of virus infectivity was
dependent on
the amount of mutant plasmid DNA used in cotransfection
(Table
1).
Interference with wt Env-mediated virus entry conferred by mutant
proteins expressed by another expression system.
To determine
whether the interference effect conferred by the zipper motif mutants
was independent of the expression vectors used, mutants 566 and 573 were analyzed by utilizing the pBSX expression system, in which Env
expression is independent of Tat protein. A smaller amount of
cell-associated gp120 was detected for mutant 566 or 573 transfection
than for wt pBSX transfection (Fig. 7A).
Transfection with mutant 566 or mutant 573 also produced a smaller
amount of cell-associated gp41 than transfection with wt plasmid (Fig.
7B). Moreover, defective recombinant viruses generated from
cotransfection with wt and mutant 566 at a plasmid DNA ratio of 1:1
showed a 64% reduction in CAT activity, and those from cotransfection
with wt and mutant 573 showed a 77% reduction in CAT activity,
compared with viruses derived from wt transfection alone (Fig. 7C).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 7.
Effect of coexpression of wt and zipper motif mutant
proteins on the wt Env-mediated virus-to-cell transmission. (A and B)
Env protein expression. COS-1 cells were transfected with 5 µg each
of pBaby, wt pBSX, or mutant pBSX, as indicated, by the DEAE-dextran
method. Two days after transfection, equal amounts of cells lysates
from each transfection were analyzed by Western blotting with
anti-gp120 (A) or Chessie 8 anti-gp41 MAb (B). (C) Ability of mutant
proteins to inhibit wt Env-induced virus entry into CD4+
cells. COS-1 cells were transfected with 5 µg of pHXBCAT Bgl and 2 µg of wt pBSX in the presence or absence of 2 µg of mutant pBSX as
indicated. Transfection with pHXBCAT Bgl and pBaby was used as a
negative control (lane 1). The total DNA amount in all transfections
was kept constant by adding pBaby DNA. Two days following transfection,
cell-free viruses were prepared, and 105 cpm of RT activity
from each virus stock was then applied to HeLa-CD4-LTR- -gal cells.
Three days after infection, cell lysates were prepared and assayed for
CAT activity.
|
|
Interference conferred by zipper motif Env mutants assayed in a
T-cell line.
To determine whether the interference effect
conferred by the zipper motif mutants was independent of the
CD4+ cells used in the env trans-complementation
assay, PM1, a CD4+-T-cell line derived from Hut78, was
utilized to assess virus entry of a defective proviral vector
pseudotyped with the wt Env or with the wt and mutant coexpressed
proteins at a wt/mutant molar ratio of 1:2. wt Env effectively mediated
virus entry into PM1 cells (Fig. 8, lane
2). Again, all of the zipper motif mutants significantly inhibited the
ability of the wt Env to mediate virus entry when they were coexpressed
with the wt Env (Fig. 8, lanes 3 to 7). Taken together, interference
studies using HeLa-CD4-LTR-
-gal and PM1 as host cells clearly
demonstrated that all zipper motif mutant Env proteins confer an
interference effect on the wt Env-mediated virus entry into
CD4+ cells.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 8.
Interference conferred by zipper motif Env mutants with
virus-to-cell transmission assayed in PM1 cells. Recombinant viruses
were generated from 293 cells cotransfected with the
cat-containing defective provirus along with the wt pSVE7 or
with the wt and mutant pSVE7 at a wt/mutant DNA ratio of 1:2 as
described in the legend to Fig. 6B. Viruses containing 8 × 104 cpm of RT activity were used to challenge PM1 cells.
Three days after infection, cell lysates were prepared and assayed for
CAT activity.
|
|
Incorporation of viral proteins into virions after cotransfection
with wt and mutant HXB2 proviruses.
To determine whether the
impaired infectivity in virus generated from wt-mutant cotransfection
was due to impairment in the late steps of the virus life cycle, 293 cells were transfected with wt or with wt and mutant 566, 573, or 580 HXB2 proviral DNA in a 1:1 ratio. Cotransfection of wt and mutant
proviruses produced levels of cell-associated and virion-associated
gag gene products comparable to those produced by wt
provirus transfection (Fig. 9A).
Virion-associated gp120 was also detected in wt-mutant cotransfection as well as in wt transfection alone (Fig. 9B). Comparable amounts of
cell-associated and virion-associated gp41 were found in wt-mutant cotransfection as well as in wt transfection alone (Fig. 9C).

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 9.
Viral protein expression in cells cotransfected with wt
and mutant HXB2 proviruses. 293 cells were transfected either with 10 µg of wt HXB2 or with 5 µg each of wt and mutant HXB2 proviruses as
indicated. Two days after transfection, equivalent portions of cell
lysates and virion fractions were analyzed with mouse anti-p24 MAb (A),
sheep anti-gp120 (B), or anti-gp41 MAb (C).
|
|
 |
DISCUSSION |
In this study we further characterized the zipper motif mutants
that we have previously described (14, 16) and found that gp41 zipper motif mutants are able to dominantly inhibit the wt Env-mediated function in an early step of the virus life cycle. Mutants
566 and 580 dominantly interfere with infectious virus production more
significantly than other mutants (Fig. 3). Although other mutants do
not exhibit a significant inhibitory effect on production of infectious
virus in the SupT1 infection study (Fig. 3), these mutants also show
significant reduction in virus infectivity compared to the wt virus
when the infectivity of mixed viruses is assessed by MAGI assay (Table
1). In addition, all mutants are able to interfere with wt Env-induced
cytopathicity (Table 2; Fig. 5) and virus entry, assayed in either the
HeLa-CD4-LTR-
-gal indicator cell line (Fig. 6 and 7; Table 1) or a
CD4+ T-cell line, PM1 (Fig. 8). Thus, the observation that
viruses derived from mixed cotransfection eventually lead to productive virus replication in SupT1 cells after a long period of culture (Fig.
3) may result from multiple infections of the residual virus infectivity which is not completely knocked out by coexpression with
mutant proviruses.
From comparison of the abilities of mutant Env proteins to complement
virus entry and to mediate syncytium formation, it was previously
reported that virus-cell and cell-cell fusion may require different
numbers of successful Env-CD4 interactions (8, 32, 36).
These studies suggested that virus-cell fusion and syncytium formation
may have different requirements for the Env structures. Since mutants
566 and 573 show different degrees of precursor processing and
gp120-gp41 association (14), it is plausible that the
hetero-oligomers formed by wt and mutant 566 and by wt and mutant 573 may have qualitative differences in their structures. It is likely that
the altered structure of the wt-mutant 573 hetero-oligomer may still be
sufficient to mediate a low level of cell-cell fusion, as shown in the
syncytium formation assay (Table 2; Fig. 5) and the SupT1 infection
study (Fig. 3), in which cell-cell fusion is also encountered. However,
such a structural alteration may be restricted for its function in
virus-cell fusion (Table 1; Fig. 6, 7, and 8). In contrast, the altered
structure formed by the wt and mutant 566 proteins may be insufficient
for mediating both syncytium formation and virus entry.
Evidence supporting that this motif contributes to the Env oligomeric
structure has been documented. Sequences or determinants that are
involved in Env oligomerization of immunodeficiency viruses have been
mapped to the ectodomain of the TM protein, in particular, to the
zipper motif (10, 22, 23, 44, 45, 54). Moreover, the gp41
zipper motif is sufficient to promote monomeric proteins to become
tetrameric or trimeric structures when it is fused to otherwise
monomeric proteins (4, 51, 58). Also, synthetic peptides or
recombinant proteins containing sequences corresponding to this motif
form a rod-like molecule with a high degree of
-helical structure
(37, 46, 47, 56, 58, 59, 62). Two peptides corresponding to
the heptad repeat sequence and a segment close to the TM region
expressed as recombinant proteins or approached by peptide modeling
form a stable, coiled-coil trimer that consists of two peptides packed
as an antiparallel heterodimer (38, 47). Recent
crystallographic data on a complex formed by the peptides containing
the N- and C-terminal sequences of the gp41 ectodomain and of a
GCN4-gp41 ectodomain chimera also demonstrate the conformation of the
gp41 ectodomain core as being an interior, parallel coiled-coil trimer
with the N terminus at its tip and the other three helices packed in
the reverse direction against the outside of the inner trimer (12,
57). Moreover, the TM protein ectodomains of Moloney murine
leukemia virus and simian immunodeficiency virus also show trimeric
conformations formed by the dimeric N- and C-terminal segments that
pack antiparallelly (5, 24, 25). These extended coiled coils
exhibit striking structural similarity to the low-pH-converted conformation of the fusogenic form of HA2, suggesting a
similar mode of function of these coiled-coil domains in membrane
fusion (40, 59).
The inhibitory effect on the wt virus infectivity conferred by these
mutants does not seem to involve the assembly and budding of Gag
proteins, since cotransfection with wt and mutant proviruses produces
levels of cell-associated and virion-associated gag gene products comparable to those produced by the wt transfection alone (Fig. 9A). In addition, virions derived from wt-mutant cotransfection contain amounts of gp41 comparable to that found in the wt virus (Fig.
9C). The interference conferred by mutant coexpression appears to be
attributable to the ability of mutant Env to form a hetero-oligomer with the wt protein which is impaired in an early step of the virus
replication cycle. The possibility that the interference is due to
competition between wt and mutant homo-oligomers for the same receptor
molecule is less likely. If a 1:1 ratio of wt to mutant plasmid DNA is
used in cotransfection and if wt and mutant proteins are present as
separate homo-oligomeric entities, at most a 50% inhibitory effect
would be observed in viruses obtained from wt-mutant coexpression.
However, as much as 80% inhibition of virus entry is detected when
mixed virus is measured in a trans-complementation assay
(Table 1). Nevertheless, the detailed molecular mechanism underlying
the interference effects conferred by these mutants remains to be
determined.
Synthetic peptides that contain sequences corresponding to the heptad
repeat sequence or the C-terminal segment of the gp41 ectodomain have
been found to be effective inhibitors in blocking virus infectivity and
membrane fusion (13, 34, 38, 60-63). It has been proposed
that the inhibitory activity of the N-terminal and C-terminal peptide
inhibitors can be attributable to their interactions with the
C-terminal and N-terminal sequences, respectively, within endogenous
gp41 (13, 40, 61). In this study we describe an anti-Env
approach, different from the use of peptide inhibitors, that targets
the heptad repeat region of gp41 ectodomain by using a
trans-dominant inhibitory mutant. Since heptad repeat
sequences are highly conserved among the TM proteins of various
membrane-enveloped viruses, the approach described here may be applied
to other viral systems in order to develop dominant-negative
mutant-based antiviral therapeutics against other viral infections.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the National Sciences
Council (NSC 85-2331-B-001-010 and NSC 86-2314-B-001-017) and from the
Institute of Biomedical Sciences at Academia Sinica, Taipei, Taiwan,
Republic of China.
We thank Hong-Huat Loh for technical help and Chien-Ting Lin for figure
labeling. We are also indebted to Douglas Platt for text editing.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Infectious Diseases, Institute of Biomedical Sciences, Academia Sinica, 128 Yen-Chiu-Yuan Rd. Section 2, Taipei, Taiwan, Republic of China. Phone: 886-2-2789-9172. Fax: 886-2-2785-8847. E-mail:
schen{at}ibms.sinica.edu.tw.
 |
REFERENCES |
| 1.
|
Abacioglu, Y. H.,
T. R. Fouts,
J. D. Laman,
E. Claasen,
S. H. Pincus,
J. P. Moore,
C. A. Roby,
R. Kamin-Lewis, and G. K. Lewis.
1994.
Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.
AIDS Res. Hum. Retroviruses
10:371-381[Medline].
|
| 2.
|
Bates, P.
1996.
Chemokine receptors and HIV-1: an attractive pair?
Cell
86:1-3[Medline].
|
| 3.
|
Bergeron, L.,
N. Sullivan, and J. Sodroski.
1992.
Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus.
J. Virol.
66:2389-2397[Abstract/Free Full Text].
|
| 4.
|
Bernstein, H. B.,
S. P. Tucker,
S. R. Kar,
S. A. McPherson,
D. T. McPherson,
J. W. Dubay,
J. Lebowitz,
R. W. Compans, and E. Hunter.
1995.
Oligomerization of the hydrophobic heptad repeat of gp41.
J. Virol.
69:2745-2750[Abstract].
|
| 5.
|
Blacklow, S. C.,
M. Lu, and P. S. Kim.
1995.
A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein.
Biochemistry
34:14955-14962[Medline].
|
| 6.
|
Broder, C. C., and D. S. Dimitrov.
1996.
HIV and the 7-transmembrane domain receptors.
Pathobiology
64:171-179[Medline].
|
| 7.
|
Bullough, P. A.,
F. M. Hughson,
J. J. Skehel, and D. C. Wiley.
1994.
Structure of influenza hemagglutinin at the pH of membrane fusion.
Nature (London)
371:37-43[Medline].
|
| 8.
|
Cao, J.,
L. Bergeron,
E. Helseth,
M. Thali,
H. Repke, and J. Sodroski.
1993.
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.
J. Virol.
67:2747-2755[Abstract/Free Full Text].
|
| 9.
|
Carr, C. M., and P. S. Kim.
1993.
A spring-loaded mechanism for the conformational change of influenza hemagglutinin.
Cell
73:823-832[Medline].
|
| 10.
|
Center, R. J.,
B. E. Kemp, and P. Poumbourios.
1997.
Human immunodeficiency virus type 1 and 2 envelope glycoproteins oligomerize through conserved sequences.
J. Virol.
71:5706-5711[Abstract].
|
| 11.
|
Chambers, P.,
C. R. Pringle, and A. J. Easton.
1990.
Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins.
J. Gen. Virol.
71:3075-3080[Abstract/Free Full Text].
|
| 12.
|
Chan, D. C.,
D. Fass,
J. M. Berger, and P. S. Kim.
1997.
Core structure of gp41 from the HIV envelope glycoprotein.
Cell
89:263-273[Medline].
|
| 13.
|
Chen, C.-H.,
T. J. Matthews,
C. B. McDanal,
D. P. Bolognesi, and M. L. Greenberg.
1995.
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral function.
J. Virol.
69:3771-3777[Abstract].
|
| 14.
|
Chen, S. S.-L.
1994.
Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41.
J. Virol.
68:2002-2010[Abstract/Free Full Text].
|
| 15.
|
Chen, S. S.-L.,
A. A. Ferrante, and E. F. Terwilliger.
1996.
Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.
Virology
226:260-268[Medline].
|
| 16.
|
Chen, S. S.-L.,
C.-N. Lee,
W.-R. Lee,
K. McIntosh, and T.-H. Lee.
1993.
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein.
J. Virol.
67:3615-3619[Abstract/Free Full Text].
|
| 17.
|
Chesebro, B.,
K. Wehrly,
J. Nishio, and S. Perryman.
1992.
Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.
J. Virol.
66:6547-6554[Abstract/Free Full Text].
|
| 18.
|
Delwart, E. L.,
G. Mosialos, and T. Gilmore.
1990.
Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat.
AIDS Res. Hum. Retroviruses
6:703-706[Medline].
|
| 19.
|
Doms, R. W.,
P. L. Earl,
S. Chakrabarti, and B. Moss.
1990.
Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain.
J. Virol.
64:3537-3540[Abstract/Free Full Text].
|
| 20.
|
D'Souza, M. P., and V. A. Harden.
1996.
Chemokines and HIV-1 second receptors.
Nat. Med.
2:1293-1300[Medline].
|
| 21.
|
Dubay, J. W.,
S. J. Roberts,
B. Brody, and E. Hunter.
1992.
Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity.
J. Virol.
66:4748-4756[Abstract/Free Full Text].
|
| 22.
|
Earl, P. L.,
R. W. Doms, and B. Moss.
1990.
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Proc. Natl. Acad. Sci. USA
87:648-652[Abstract/Free Full Text].
|
| 23.
|
Earl, P. L., and B. Moss.
1993.
Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein.
AIDS Res. Hum. Retroviruses
9:589-594[Medline].
|
| 24.
|
Fass, D.,
S. C. Harrison, and P. S. Kim.
1996.
Retrovirus envelope domain at 1.7Å resolution.
Nat. Struct. Biol.
3:465-469[Medline].
|
| 25.
|
Fass, D., and P. S. Kim.
1995.
Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin.
Curr. Biol.
5:1377-1383[Medline].
|
| 26.
|
Feinberg, M. B., and D. Trono.
1992.
Intracellular immunization: trans-dominant mutants of HIV gene products as tools for the study and interruption of viral replication.
AIDS Res. Hum. Retroviruses
8:1013-1022[Medline].
|
| 27.
|
Freed, E. O.,
E. L. Delwart,
G. L. Buchschacher, Jr., and A. T. Panganiban.
1992.
A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.
Proc. Natl. Acad. Sci. USA.
89:70-74[Abstract/Free Full Text].
|
| 28.
|
Gallaher, W. R.,
J. M. Ball,
R. F. Garry,
M. C. Griffin, and R. C. Montelaro.
1989.
A general model for the transmembrane proteins of HIV and other retroviruses.
AIDS Res. Hum. Retroviruses
5:431-440[Medline].
|
| 29.
|
Gelderblom, H. R.,
E. H. Hausmann,
M. Ozel,
G. Pauli, and M. A. Koch.
1988.
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
Virology
156:171-176.
|
| 30.
|
Göttlinger, H. G.,
T. Dorfman,
E. A. Cohen, and W. A. Haseltine.
1993.
Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses.
Proc. Natl. Acad. Sci. USA
90:7381-7385[Abstract/Free Full Text].
|
| 31.
|
Grief, C.,
D. J. Hockley,
C. E. Fromholc, and P. A. Kitchin.
1989.
The morphology of simian immunodeficiency virus as shown by negative staining electron microscopy.
J. Gen. Virol.
70:2215-2219[Abstract/Free Full Text].
|
| 32.
|
Helseth, E.,
M. Kowalski,
D. Gabuzda,
U. Olshevsky,
W. Haseltine, and J. Sodroski.
1990.
Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants.
J. Virol.
64:2416-2420[Abstract/Free Full Text].
|
| 33.
|
Herskowitz, I.
1987.
Functional inactivation of genes by dominant negative mutations.
Nature (London)
329:219-222[Medline].
|
| 34.
|
Jiang, S.,
K. Lin,
N. Strick, and A. R. Neurath.
1993.
HIV-1 inhibition by a peptide.
Nature (London)
365:113[Medline].
|
| 35.
|
Kimpton, J., and M. Emerman.
1992.
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated -galactosidase gene.
J. Virol.
66:2232-2239[Abstract/Free Full Text].
|
| 36.
|
Kowalski, M.,
L. Bergeron,
T. Dorfman,
W. Haseltine, and J. Sodroski.
1991.
Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
J. Virol.
65:281-291[Abstract/Free Full Text].
|
| 37.
|
Lawless, M. K.,
S. Barney,
K. L. Guthrie,
T. B. Bucy,
S. R. Petteway, Jr., and G. Merutka.
1996.
HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
Biochemistry
35:13697-13708[Medline].
|
| 38.
|
Lu, M.,
S. C. Blacklow, and P. S. Kim.
1995.
A trimeric structural domain of the HIV-1 transmembrane glycoprotein.
Nat. Struct. Biol.
2:1075-1082[Medline].
|
| 39.
|
Lusso, P.,
F. Cocchi,
C. Balotta,
P. D. Markham,
A. Louie,
P. Farci,
R. Pai,
R. C. Gallo, and M. S. Reitz, Jr.
1995.
Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line tropic HIV-1.
J. Virol.
69:3712-3720[Abstract].
|
| 40.
|
Matthews, T. J.,
C. Wild,
C.-H. Chen,
D. P. Bolognesi, and M. L. Greenberg.
1994.
Structural rearrangements in the transmembrane glycoprotein after receptor binding.
Immunol. Rev.
140:93-104[Medline].
|
| 41.
|
Moore, J. P.,
B. A. Jameson,
R. A. Weiss, and Q. J. Sattentau.
1993.
The HIV-cell fusion reaction, p. 233-289.
In
J. Bentz (ed.), Viral fusion mechanisms. CRC Press, Boca Raton, Fla.
|
| 42.
|
Patarca, R., and W. A. Haseltine.
1984.
Similarities among retrovirus proteins.
Nature (London)
312:496[Medline].
|
| 43.
|
Pinter, A.,
W. J. Honnen,
S. A. Tilley,
C. Bona,
H. Zaghouani,
M. K. Gorny, and S. Zolla-Pazner.
1989.
Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.
J. Virol.
63:2674-2679[Abstract/Free Full Text].
|
| 44.
|
Poumbourios, P.,
W. E. Ahmar,
D. A. McPhee, and B. E. Kemp.
1995.
Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.
J. Virol.
69:1209-1218[Abstract].
|
| 45.
|
Poumbourios, P.,
K. A. Wilson,
R. J. Center,
W. E. Ahmar, and B. E. Kemp.
1997.
Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic -helical/leucine zipper-like sequence.
J. Virol.
71:2041-2049[Abstract].
|
| 46.
|
Rabenstein, M., and Y.-K. Shin.
1995.
A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation.
Biochemistry
34:13390-13397[Medline].
|
| 47.
|
Rabenstein, M. D., and Y.-K. Shin.
1996.
HIV-1 gp41 tertiary structure studied by EPR spectroscopy.
Biochemistry
35:13922-13928[Medline].
|
| 48.
|
Ratner, L.,
A. Fisher,
L. L. Jagodzinski,
H. Mitsuya,
R.-S. Liou,
R. C. Gallo, and F. Wong-Staal.
1987.
Complete nucleotide sequences of functional clones of the AIDS virus.
AIDS Res. Hum. Retroviruses
3:57-69[Medline].
|
| 49.
|
Rey, M.-A.,
B. Krust,
A. G. Laurent,
L. Montagnier, and A. G. Hovanessian.
1989.
Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing.
J. Virol.
63:647-658[Abstract/Free Full Text].
|
| 50.
|
Rey, M.-A.,
A. G. Laurent,
J. McClure,
B. Krust,
L. Montagnier, and A. G. Hovanessian.
1990.
Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers.
J. Virol.
64:922-926[Abstract/Free Full Text].
|
| 51.
|
Shugars, D. C.,
C. T. Wild,
T. K. Greenwell, and T. J. Matthews.
1996.
Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41.
J. Virol.
70:2982-2991[Abstract].
|
| 52.
|
Steffy, K. R., and F. Wong-Staal.
1993.
Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant.
J. Virol.
67:1854-1859[Abstract/Free Full Text].
|
| 53.
|
Steimer, K. S.,
J. P. Puma,
M. D. Power,
M. A. Powers,
C. George-Nascimento,
J. C. Stephans,
J. A. Levy,
R. Sanchez-Pescador,
P. Luciw,
P. J. Barr, and R. A. Hallewell.
1986.
Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral antigen p25 gag expressed in bacteria.
Virology
150:283-290[Medline].
|
| 54.
|
Thomas, D. J.,
J. S. Wall,
J. F. Hainfeld,
M. Kaczorek,
F. P. Booy,
B. L. Trus,
F. A. Eiserling, and A. C. Steven.
1991.
gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains.
J. Virol.
65:3797-3803[Abstract/Free Full Text].
|
| 55.
|
Unutmaz, D., and D. R. Littman.
1997.
Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing.
Proc. Natl. Acad. Sci. USA
94:1615-1618[Free Full Text].
|
| 56.
|
Weissenhorn, W.,
L. Calder,
A. Dessen,
T. Laue,
J. J. Skehel, and D. C. Wiley.
1997.
Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli.
Proc. Natl. Acad. Sci. USA
94:6065-6069[Abstract/Free Full Text].
|
| 57.
|
Weissenhorn, W.,
A. Dessen,
S. C. Harrison,
J. J. Skehel, and D. C. Willey.
1997.
Atomic structure of the ectodomain from HIV-1 gp41.
Nature (London)
387:426-430[Medline].
|
| 58.
|
Weissenhorn, W.,
S. A. Wharton,
L. J. Calder,
P. L. Earl,
B. Moss,
E. Aliprandis,
J. J. Skehel, and D. C. Wiley.
1996.
The ectodomain of HIV-1 env subunit gp41 forms a soluble, -helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide.
EMBO J.
15:1507-1514[Medline].
|
| 59.
|
Wild, C.,
J. W. Dubay,
T. Greenwell,
T. Baird, Jr.,
T. G. Oas,
C. McDanal,
E. Hunter, and T. Matthews.
1994.
Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex.
Proc. Natl. Acad. Sci. USA
91:12676-12680[Abstract/Free Full Text].
|
| 60.
|
Wild, C.,
T. Greenwell, and T. Matthews.
1993.
A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion.
AIDS Res. Hum. Retroviruses
9:1051-1053[Medline].
|
| 61.
|
Wild, C.,
T. Greenwell,
D. Shugars,
L. Rimsky-Clarke, and T. Matthews.
1995.
The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure.
AIDS Res. Hum. Retroviruses
11:323-325[Medline].
|
| 62.
|
Wild, C.,
T. Oas,
C. McDanal,
D. Bolognesi, and T. Matthews.
1992.
A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
Proc. Natl. Acad. Sci. USA
89:10537-10541[Abstract/Free Full Text].
|
| 63.
|
Wild, C.,
D. C. Shugars,
T. K. Greenwell,
C. B. McDonal, and T. J. Matthews.
1994.
Peptides corresponding to a predictive -helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
Proc. Natl. Acad. Sci. USA
91:9770-9774[Abstract/Free Full Text].
|
| 64.
|
Wilson, I. A.,
J. J. Skehel, and D. C. Wiley.
1981.
Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3Å resolution.
Nature (London)
289:366-373[Medline].
|
J Virol, June 1998, p. 4765-4774, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chen, S. S.-L., Yang, P., Ke, P.-Y., Li, H.-F., Chan, W.-E., Chang, D.-K., Chuang, C.-K., Tsai, Y., Huang, S.-C.
(2009). Identification of the LWYIK Motif Located in the Human Immunodeficiency Virus Type 1 Transmembrane gp41 Protein as a Distinct Determinant for Viral Infection. J. Virol.
83: 870-883
[Abstract]
[Full Text]
-
He, Y., Liu, S., Li, J., Lu, H., Qi, Z., Liu, Z., Debnath, A. K., Jiang, S.
(2008). Conserved Salt Bridge between the N- and C-Terminal Heptad Repeat Regions of the Human Immunodeficiency Virus Type 1 gp41 Core Structure Is Critical for Virus Entry and Inhibition. J. Virol.
82: 11129-11139
[Abstract]
[Full Text]
-
Long, G., Pan, X., Vlak, J. M.
(2008). Conserved Leucines in N-Terminal Heptad Repeat HR1 of Envelope Fusion Protein F of Group II Nucleopolyhedroviruses Are Important for Correct Processing and Essential for Fusogenicity. J. Virol.
82: 2437-2447
[Abstract]
[Full Text]
-
Chan, W.-E., Chuang, C.-K., Yeh, S.-H., Chang, M.-S., Chen, S. S.-L.
(2006). Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.. J. Virol.
80: 3225-3237
[Abstract]
[Full Text]
-
Song, C., Micoli, K., Hunter, E.
(2005). Activity of the Mason-Pfizer Monkey Virus Fusion Protein Is Modulated by Single Amino Acids in the Cytoplasmic Tail. J. Virol.
79: 11569-11579
[Abstract]
[Full Text]
-
Chan, W.-E., Lin, H.-H., Chen, S. S.-L.
(2005). Wild-Type-Like Viral Replication Potential of Human Immunodeficiency Virus Type 1 Envelope Mutants Lacking Palmitoylation Signals. J. Virol.
79: 8374-8387
[Abstract]
[Full Text]
-
Chan, W.-E., Wang, Y.-L., Lin, H.-H., Chen, S. S.-L.
(2004). Effect of Extension of the Cytoplasmic Domain of Human Immunodeficiency Type 1 Virus Transmembrane Protein gp41 on Virus Replication. J. Virol.
78: 5157-5169
[Abstract]
[Full Text]
-
Song, C., Hunter, E.
(2003). Variable Sensitivity to Substitutions in the N-Terminal Heptad Repeat of Mason-Pfizer Monkey Virus Transmembrane Protein. J. Virol.
77: 7779-7785
[Abstract]
[Full Text]
-
Sanders, R. W., Vesanen, M., Schuelke, N., Master, A., Schiffner, L., Kalyanaraman, R., Paluch, M., Berkhout, B., Maddon, P. J., Olson, W. C., Lu, M., Moore, J. P.
(2002). Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1. J. Virol.
76: 8875-8889
[Abstract]
[Full Text]
-
Lee, S.-F., Ko, C.-Y., Wang, C.-T., Chen, S. S.-L.
(2002). Effect of Point Mutations in the N Terminus of the Lentivirus Lytic Peptide-1 Sequence of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 on Env Stability. J. Biol. Chem.
277: 15363-15375
[Abstract]
[Full Text]
-
Vicient, C. M., Kalendar, R., Schulman, A. H.
(2001). Envelope-Class Retrovirus-Like Elements Are Widespread, Transcribed and Spliced, and Insertionally Polymorphic in Plants. Genome Res
11: 2041-2049
[Abstract]
[Full Text]
-
Lerner, D. L., Elder, J. H.
(2000). Expanded Host Cell Tropism and Cytopathic Properties of Feline Immunodeficiency Virus Strain PPR Subsequent to Passage through Interleukin-2-Independent T Cells. J. Virol.
74: 1854-1863
[Abstract]
[Full Text]
-
Chen, S. S.-L., Lee, S.-F., Chuang, C.-K., Raj, V. S.
(1999). trans-Dominant Interference with Human Immunodeficiency Virus Type 1 Replication and Transmission in CD4+ Cells by an Envelope Double Mutant. J. Virol.
73: 8290-8302
[Abstract]
[Full Text]
-
Lee, S.-F., Wang, C.-T., Liang, J. Y.-P., Hong, S.-L., Huang, C.-C., Chen, S. S.-L.
(2000). Multimerization Potential of the Cytoplasmic Domain of the Human Immunodeficiency Virus Type 1 Transmembrane Glycoprotein gp41. J. Biol. Chem.
275: 15809-15819
[Abstract]
[Full Text]